Today: 28 October 2025
Subscribe
From Cannabis Clinics to Bitcoin Billions: KindlyMD (NAKA) Stock’s Wild 2025 Ride
28 October 2025
 ·  ·  ·  · 
6 mins read

From Cannabis Clinics to Bitcoin Billions: KindlyMD (NAKA) Stock’s Wild 2025 Ride

by
  • Stock Rollercoaster: KindlyMD, Inc. (NASDAQ: NAKA) – a Utah-based telehealth and cannabis-focused healthcare firm – saw its stock skyrocket over 600% in mid-2025 after pivoting into Bitcoin, then plunge over 95% from all-time highs. Shares hit ~$29 after the merger (up 650% in one day) [1], but recently sank as low as $0.65 amid dilution fears – a 96% collapse from the peak [2]. As of this week, NAKA trades around $1.00 per share after a brief 20% rebound [3] [4].
  • Bitcoin Treasury Pivot: In August 2025, KindlyMD merged with Nakamoto Holdings, a Bitcoin holding company led by crypto investor David Bailey, to transform into a “Bitcoin treasury” vehicle [5] [6]. The deal brought $710 million in fresh financing (including a $510M PIPE at $1.12/share and $200M in notes) [7], enabling KindlyMD to buy ~5,744 BTC (worth ~$635M at the time) as part of its new treasury reserve strategy [8]. The company even filed for an “at-the-market” stock offering up to $5 billion – effectively authorizing massive equity sales – to fund more Bitcoin purchases [9] [10]. This bold crypto bet has rattled investors with fears of heavy dilution.
  • Recent News & Deals: In early October, KindlyMD secured a $203 million term loan from Two Prime Lending [11], using it to redeem a $200M convertible note and shore up its balance sheet [12]. Days later, the company announced a partnership with Antalpha – a digital asset fintech – including a non-binding LOI for a $250 million, 5-year convertible note to further expand KindlyMD’s Bitcoin holdings and replace the Two Prime loan [13] [14]. Antalpha even provided an interim Bitcoin-backed bridge loan [15] [16]. Management touts this as a long-term financing solution “backing Bitcoin companies with Bitcoin companies,” in CEO David Bailey’s words [17]. These moves aim to refinance debt on better terms, protect the firm’s Bitcoin trove, and support growth – but the convertible notes could still dilute shareholders if eventually converted [18].
  • Expert Reactions:Market sentiment is sharply divided. Weiss Ratings recently reaffirmed a “Sell (D–)” rating on NAKA [19], citing a negative outlook as the stock hovers under $1 and the company bleeds red ink (NAKA reported a –$0.34 EPS last quarter) [20]. Other analysts are more optimistic: B. Riley initiated coverage with a Buy rating and a $2.00 price target [21], and the consensus of a few analysts stands at “Hold” with a price target around $5 [22] – well above current levels. Independent observers have flagged KindlyMD’s valuation as stretched given its tiny revenues and big losses. “KindlyMD exhibits troubling financial fundamentals with deeply negative profitability… The market reacted unfavorably to [its] bold investment shift towards a Bitcoin treasury, raising stakeholder concerns,” one stock analysis noted [23] [24]. On the other hand, CEO David Bailey urges patience and conviction: “We know resilience and discipline separate those who endure from those who fade… for those shareholders who have come looking for a trade, I encourage you to exit,” he wrote in a September shareholder letter [25], implying only long-term believers should stick around through the volatility.
  • Core Business & Sector Context: Lost in the crypto hype is KindlyMD’s original healthcare business. Founded in 2019, KindlyMD operates clinics and telehealth services in Utah focused on holistic pain management, primary care, mental health, and alternative therapies [26]. Notably, it is a leading provider of medical cannabis card evaluations under Utah’s program, with clinics that help patients obtain cannabis for conditions like chronic pain or PTSD [27] [28]. This “plant-based therapy” niche made KindlyMD a key player in Utah’s medical cannabis scene, and the company integrates those services with traditional care (even offering weight-loss and sleep treatments). The healthcare/cannabis sector itself faces regulatory hurdles and competition – e.g. strict state rules for telemedicine and cannabis prescriptions – but also rising demand for accessible, integrative care. KindlyMD’s challenge (and opportunity) will be balancing its high-growth crypto ambitions with the needs of its medical patients and operations. Any changes in telehealth regulations or cannabis laws in its market could impact patient volumes, while competition from other telehealth providers remains a factor. So far, KindlyMD insists it will continue its “patient-first” care model even as it pursues Bitcoin treasury management [29].
  • Market Outlook: Going forward, volatility is likely to remain extreme for NAKA stock. The company’s roughly $418 million market cap at $1/share suggests investors are valuing it at less than its Bitcoin holdings (which, at ~5,744 BTC, would be ~$600+ million at recent prices) – reflecting a “crypto discount” due to dilution risks and unprofitability. In fact, NAKA briefly traded below the value of its Bitcoin per share when panic selling hit in September [30] [31]. Bulls argue that if Bitcoin’s price surges further (it topped $123k in August [32]) and KindlyMD can avoid excessive share dilution, the stock could re-rate upward to close that gap. They point to analogies like MicroStrategy – a software firm turned Bitcoin vault – whose stock often tracks the price of its BTC stash. Any positive catalyst – e.g. closing the Antalpha $250M financing on favorable terms, or Bitcoin running to new highs – might spark a speculative rally in NAKA. In fact, the stock just jumped 20% in a single day amid a broader tech rally [33], showing how quickly sentiment can swing.
  • Risks and Challenges: However, skeptics note enormous risks. KindlyMD’s financials are deeply in the red – last quarter’s net margin was –244% [34] on a mere $0.4 million in revenue [35] – meaning its healthcare business isn’t yet covering costs, let alone the interest on its new debt. The aggressive ATM stock sale plan (up to $5B) could dramatically dilute existing shareholders if executed, potentially increasing the share count by many multiples. Even the hint of large share issuance has crushed the stock before (NAKA fell 22% when the ATM was announced, and 55% when PIPE lockup shares were registered for sale) [36] [37]. Regulatory scrutiny is another consideration: as a quasi-crypto investment vehicle, KindlyMD must comply with both SEC reporting and healthcare regulations – a unique juggling act. Competition is two-fold: on the crypto side, other firms and ETFs offer Bitcoin exposure without the complication of a healthcare business; on the medical side, KindlyMD competes with traditional clinics and telehealth startups, which may now have an edge if management’s attention (and cash) is diverted to Bitcoin.

Market Analysis & Forecast: For now, analysts and investors appear in “wait and see” mode. Near-term catalysts will be pivotal. These include the finalization (or not) of the Antalpha $250M convertible deal – which would inject capital but on what terms? – and the company’s next earnings report (to show if core healthcare revenue is growing or still minuscule). If Bitcoin’s price continues to climb in late 2025, it could boost KindlyMD’s asset value and perhaps its stock; conversely, a crypto downturn or interest rate spike could hurt both the value of its BTC and its ability to raise funds cheaply. Price forecasts vary widely: some Wall Street firms see NAKA recovering to a few dollars (Maxim Group pegged a bullish $8 target earlier [38]), while rating agencies like Weiss effectively warn it could go lower. Given the speculative nature of this stock, extreme swings are likely to persist.

Bottom Line: KindlyMD’s story is a remarkable blend of healthcare and high finance in 2025. In the span of months, it morphed from a small telehealth and medical cannabis provider into an ambitious Bitcoin-holding vehicle – a strategy that sent its stock on a boom-and-bust ride. The company is now flush with crypto assets and big plans, but also faces skeptical investors and the task of executing on two very different fronts. Can a company really treat patients by day and trade Bitcoin by night? KindlyMD is testing that thesis. For the general public and investors, the coming months will show whether this bold bet pays off or becomes a cautionary tale. As one expert put it, “KindlyMD’s ability to align its Bitcoin vision with its healthcare mission will determine if it can heal its stock performance – or if more pain is ahead.” [39] [40]

Sources:

  • CoinDesk – KindlyMD merges with Nakamoto; stock soars 650% [41] [42]; KindlyMD $5B Bitcoin treasury stock sale, BTC purchase [43] [44]; NAKA plunges on PIPE sell-off, CEO letter [45] [46].
  • Company Press Release via StockTitan – $203M Two Prime loan & $200M note redemption (Oct 3, 2025) [47] [48]; Antalpha $250M convertible note partnership (Oct 7, 2025) [49] [50].
  • Investing.com – KindlyMD & Antalpha partnership details; company background [51] [52].
  • StocksToTrade analysis – Market reaction to $5B ATM and crypto pivot [53] [54].
  • MarketBeat/Yahoo Finance – Analyst ratings (Weiss D– sell, B. Riley buy), stock stats [55] [56]; Q2 2025 financial results (revenue, EPS, margins) [57].
  • KindlyMD Company Website – About the healthcare business (clinics, telehealth, cannabis card services) [58] [59].
Is Cannabis Stocks Worth It? #shorts #crypto #stocks
Watch this video on YouTube.

References

1. www.coindesk.com, 2. www.coindesk.com, 3. www.marketbeat.com, 4. stocktwits.com, 5. www.coindesk.com, 6. www.investing.com, 7. www.coindesk.com, 8. www.coindesk.com, 9. www.coindesk.com, 10. www.coindesk.com, 11. www.stocktitan.net, 12. www.stocktitan.net, 13. www.stocktitan.net, 14. www.stocktitan.net, 15. www.stocktitan.net, 16. www.investing.com, 17. www.stocktitan.net, 18. www.stocktitan.net, 19. www.marketbeat.com, 20. www.marketbeat.com, 21. www.marketbeat.com, 22. www.marketbeat.com, 23. stockstotrade.com, 24. stockstotrade.com, 25. www.coindesk.com, 26. investors.kindlymd.com, 27. kindlymd.com, 28. kindlymd.com, 29. www.coindesk.com, 30. www.coindesk.com, 31. www.coindesk.com, 32. www.coindesk.com, 33. www.marketbeat.com, 34. www.marketbeat.com, 35. www.marketbeat.com, 36. stockstotrade.com, 37. www.coindesk.com, 38. www.marketbeat.com, 39. stockstotrade.com, 40. www.marketbeat.com, 41. www.coindesk.com, 42. www.coindesk.com, 43. www.coindesk.com, 44. www.coindesk.com, 45. www.coindesk.com, 46. www.coindesk.com, 47. www.stocktitan.net, 48. www.stocktitan.net, 49. www.stocktitan.net, 50. www.stocktitan.net, 51. www.investing.com, 52. www.investing.com, 53. stockstotrade.com, 54. stockstotrade.com, 55. www.marketbeat.com, 56. www.marketbeat.com, 57. www.marketbeat.com, 58. investors.kindlymd.com, 59. kindlymd.com

Tags:

Mateusz Kaczmarek Latest posts

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

  1. Breaking: NASA’s X-59 Quiet Supersonic Jet Takes Off – Travel Times Could Halve
  2. Accenture’s Bold AI Gamble: Layoffs, Stock Rally and 25-Year Anniversary Unveiled
  3. Nokia Stock Explodes on AI, 5G & Nvidia News – Analysts Pile In with ‘Buy’ Ratings
  4. Retail Shock: Target Slashes 1,800 Jobs — Is the Economy in Danger?

Stock Market Today

  • Tuesday Sector Leaders: Materials Lead; Industrials Mixed Midday Trading
    October 28, 2025, 4:20 PM EDT. Through midday Tuesday, the Materials sector leads with a 0.3% gain, helped by Sherwin-Williams (SHW) and Nucor (NUE), up about 5.5% and 4.9% intraday. The Materials Select Sector SPDR ETF (XLB) is up 0.4% and 7.66% YTD; SHW and NUE together account for roughly 11.2% of XLB. The Industrial sector is the second best performer, down only 0.1%, with PayPal (PYPL) and United Parcel Service (UPS) rising 8.0% and 7.9% on the day. The Industrial Select Sector SPDR ETF (XLI) is down 0.1% today, but up 19.20% YTD. PYPL is down 11.10% YTD and UPS down 19.73% YTD, with UPS representing about 1.5% of XLI. Across sectors, eight are lower and one up for the S&P 500 components; overall, the mood is mixed.
  • Fed Rate Cut Expectations Keep Crypto Traders Eyeing Bitcoin and Ethereum
    October 28, 2025, 4:10 PM EDT. Markets expect a 25-basis-point Fed rate cut, with a ~97.8% probability, but crypto impacts remain debated. Analysts say ending quantitative tightening could be a tailwind for Bitcoin as inflation tolerance rises, with Bank of America and JPMorgan signaling QT may end soon. Bitcoin traded around $114,850 after a flat day; Ethereum hovered just above $4,100, up versus a week ago but down on the day. Traders believe the cut is largely priced in, and easier policy historically supports crypto and risk assets into 2026. The key question is whether the Fed will unwind QT and how that would affect liquidity and inflation expectations, shaping the near-term moves for BTC, ETH, and broader markets.
  • Carter's (CRI) Dips After Weak Q3 Results and Restructuring Plan
    October 28, 2025, 4:03 PM EDT. Carter's (CRI) shares fell about 3.9% after reporting a weak third-quarter with EPS of $0.32 vs $1.62 a year earlier and revenue of about $758 million. The company announced a sweeping restructuring: closing about 150 stores and cutting 300 corporate jobs, while tariffs and higher product costs pressured margins, leading to suspended fiscal 2025 guidance. The stock is down 41.8% YTD and trades around $31.31, well below a 52-week high of $57.01. The move underscores how trade tensions weigh on consumer discretionary names; a potential easing of tariffs could lift margins and sales. The report notes the sector's sensitivity to international relations and suggests investors may view the decline as meaningful but not a fundamental change in the business.
  • Great-West Lifeco's Series P Preferred Shares Cross 5.5% Yield Threshold
    October 28, 2025, 4:00 PM EDT. Great-West Lifeco Inc's Non-Cumulative First Preferred Shares, Series P (GWO-PRP.TO) traded near $24.53 in Tuesday's session, delivering a yield above 5.5% based on the quarterly dividend (annualized to $1.35). The shares stood at about a 1.60% discount to liquidation preference. Importantly, the non-cumulative feature means missed payments aren't carried forward before resuming a common dividend. On the day, the common shares (GWO.TO) rose modestly alongside a slight uptick in GWO-PRP. Investors should weigh the discount to liquidation and the non-cumulative structure when assessing risk and return in this preferreds issue.
  • Manulife Financial's Series 3 Preferred Shares Cross 5% Yield Territory
    October 28, 2025, 3:58 PM EDT. On Tuesday, Manulife Financial Corp's Non-cumulative Rate Reset Class A Shares, Series 3 (MFC-PRC.TO) traded with a dividend annualized at $1.125, placing the security near a 5% yield as low as $22.42. At last close, MFC.PRC was at a ~9.72% discount to its liquidation preference. Note the shares are non-cumulative, meaning missed payments aren't carried forward before resuming a common dividend. The day's action showed the PRC off about 0.7%, while the common shares (MFC.TO) were also down roughly 0.7%. Investors should weigh the favorable yield against the non-cumulative structure and the risk of price swings tied to interest rates and the issuer's credit.
Go toTop